Contact information
Research groups
Lisa Stockdale
MPH, PhD
Senior Immunologist
Pre-erythrocytic Malaria and Outbreak Pathogen Clinical Trials
Senior Immunologist
Senior immunologist in the pre-erythrocytic malaria vaccine group. I coordinate the immunology of a Phase 3 vaccine clinical trial on R21/Matrix M.
Research interests include correlates of vaccine-induced protection, antibody glycosylation and immunological interactions between different pathogens.
I am an Early Career Researcher representative for NDM and a lead of the Jenner Research Staff Network.
Recent publications
-
A randomised trial of malaria vaccine R21/Matrix-M™ with and without antimalarial drugs in Thai adults.
Journal article
Hanboonkunupakarn B. et al, (2024), NPJ vaccines, 9
-
Safety and immunogenicity of varied doses of R21/Matrix-M™ vaccine at three years follow-up: A phase 1b age de-escalation, dose-escalation trial in adults, children, and infants in Kilifi-Kenya
Preprint
Sang S. et al, (2024)
-
The public health impact and cost-effectiveness of the R21/Matrix-M malaria vaccine: a mathematical modelling study.
Journal article
Schmit N. et al, (2024), The Lancet. Infectious diseases, 24, 465 - 475
-
Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial.
Journal article
Datoo MS. et al, (2024), Lancet (London, England), 403, 533 - 544
-
Distinct glycosylation and functional profile of typhoid vaccine-induced antibodies in a UK challenge study and Nepalese children
Journal article
Stockdale LK. et al, (2022), Frontiers in Analytical Science, 2